|
Characteristic
|
N o. of patients
|
%
|
|---|
|
Patients evaluable
|
41
|
100
|
|
Age, years
| | |
|
Median
|
60
|
/
|
|
Range
|
32-75
| |
|
ECOG PS
| | |
|
0
|
13
|
32
|
|
1
|
21
|
51
|
|
2
|
7
|
17
|
|
Tumor histology/citology
| | |
|
Serous adenocarcinoma
|
10
|
24.5
|
|
Adenocarcinoma
|
7
|
17
|
|
Papillary serous
|
6
|
15
|
|
Clear cell adenocarcinoma
|
2
|
5
|
|
Endometrioid
|
3
|
7
|
|
Mucinous adenocarcinoma
|
3
|
7
|
|
Poorly differentiated
|
10
|
24.5
|
|
Stage at diagnosis
| | |
|
I,II
|
2
|
5
|
|
III (A, B, C)
|
33 (10, 12, 11)
|
80
|
|
IV
|
6
|
15
|
|
N of prior chemotherapy regimens
| | |
|
1
|
3
|
7
|
|
2
|
12
|
29
|
|
≥3
|
26
|
64
|
|
N of prior platinum-based regimens
| | |
|
1
|
23
|
56
|
|
2
|
9
|
22
|
|
3
|
9
|
22
|
- Abbreviations: ECOG PS, Eastern Cooperative Oncoloy Group Performance Status.
